SONN logo
SONN NASDAQ US

Sonnet BioTherapeutics Holdings, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Jul 2005
$1.26
-1.84 (-59.4%)
2
Quality Score
fail
Mkt Cap
$8.9M
ROE
-416.5%
Margin
-316.1%
D/E
0.00
Beta
1.65
52W
$1–$19

Wall Street Consensus

7 analysts · Apr 2026
2
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
85.7%
Buy Rating

Price Chart

Similar Stocks

ACXP
Acurx Pharmaceuticals Inc
$5.8M
BCAB
Bioatla Inc
$33.5M
LNAI
Lunai Bioworks Inc
$20.7M
BOLT
Bolt Biotherapeutics Inc
$10.5M
APRE
Aprea Therapeutics Inc
$6.0M
GRDX
GridAI Technologies Corp
RNAZ
Transcode Therapeutics Inc
$6.3M

Earnings

Beat rate: 50.0%
Next Report May 11, 2026
Quarter EPS Est EPS Act Surprise
Jun 2026 — — —
Jun 2025 $-0.50 $-0.95 $-0.45
Mar 2025 $-0.94 $-0.89 +$0.05
Dec 2024 $-1.42 $-1.56 $-0.14

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) — -416.5% -416.5% -416.5% -416.5% -416.5%
P/E (TTM) — — — — — —
Net Margin — -316.1% -316.1% -316.1% -316.1% -316.1%
Gross Margin — 6.8% 6.8% 6.8% 6.8% 6.8%
D/E Ratio — 0.00 0.00 0.00 0.00 0.00
Current Ratio 0.26 1.03 0.26 0.26 0.26 0.26

Key Ratios

ROA (TTM)
-342.2%
P/S (TTM)
8.92
P/B
1.6
EPS (TTM)
$-6.73
CF/Share
$-34.70
Rev Growth 3Y
-66.1%
52W High
$19.30
52W Low
$1.08
$1.08 52-Week Range $19.30

How does SONN compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

SONN AAPG ABEO ABOS ABP

SONN valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
8.9
▼ 31% below peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
1.6
▼ 36% below peers (2.5)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

SONN profitability vs Biotechnology peers

ROE
-416.5%
▼ 519% below peers (-67.3%)
vs Peers
vs Industry
Weak
Net margin
-316.1%
▼ 10% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
6.8%
▼ 91% below peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-342.2%
▼ 633% below peers (-46.7%)
vs Peers
vs Industry
Weak

SONN financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
0.3
▼ 94% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.7
▲ 71% above peers (1.0)
vs Peers
vs Industry
More volatile

SONN fundamentals radar

SONN Peer median Industry

SONN profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

SONN vs peers: key metrics

Latest News

No related news yet